Hypermethylation of antisense long noncoding RNAs in acute lymphoblastic leukemia.

Autor: Arthur G; Department of Pathology & Anatomical Sciences, University of Missouri-Columbia, Columbia, MO 65212, USA.; MU Informatics Institute, University of Missouri-Columbia, Columbia, MO 65212, USA., Almamun M; Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA., Taylor K; Department of Pathology & Anatomical Sciences, University of Missouri-Columbia, Columbia, MO 65212, USA.
Jazyk: angličtina
Zdroj: Epigenomics [Epigenomics] 2017 May; Vol. 9 (5), pp. 635-645. Date of Electronic Publication: 2017 Jan 17.
DOI: 10.2217/epi-2016-0156
Abstrakt: Aim: Long noncoding RNAs serve critical regulatory functions highly specific for a tissue and its developmental stage. Antisense long ncRNA (AS-lncRNA) methylation changes in acute lymphoblastic leukemia (ALL) versus normal pre-B-cell lymphoblasts were evaluated to identify potential differential methylation in this group of genes.
Materials & Methods: The methylome of ALL and normal lymphoblasts was examined by the methylated CpG island recovery assay followed by NGS.
Conclusion: The potential effect of trans regulation by AS-lncRNA through DNA/RNA binding is significant as sequence alignment analysis of the 25 most differentially methylated AS-lncRNAs revealed 368 genes containing highly similar sequences with a median nucleotide identity of 90.8% and binding span of 122 base pairs. Regulation of biological processes and anatomical structure development were over represented. ALL classification schemes based on AS-lncRNA methylation can provide new insights into its pathogenesis and treatment.
Databáze: MEDLINE